Sushma Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sushma Singh has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
Anindita Paul
Department of Biotechnology, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali, 160062, Punjab, India
10 shared publications- Neelagiri Soumya
Department of Biotechnology, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali 160062, Punjab, India
8 shared publications Neeradi Dinesh
Department of Biotechnology, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali 160062, Punjab, India
8 shared publicationsNeerupudi Kishore Babu
Department of Biotechnology, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali, 160062, Punjab, India
8 shared publicationsPreet Kamal Kaur
Department of Biotechnology, National Institute of Pharmaceutical Education and Research, SAS Nagar, (Mohali), Punjab, India
7 shared publications- Rentala Madhubala
School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
7 shared publications
Latest Publications
- 21 January 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (3) , 135
Emerging therapeutic drug targets in amino acid and protein biosynthesis pathways against ESKAPE and non-ESKAPE pathogens: a comprehensive review
Overuse and misuse of antibiotics used for treating bacterial infections has resulted in ineffectiveness of the drugs and hence increase in the cases of antimicrobial resistance. This has precipitated to the need for research and development of novel strategies to target pathogenic microbes. ESKAPE pathogens include high priority pathogens such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae (sometimes K. aerogenes), Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species (e.g., E. cloacae) which are responsible for causing healthcare associated infections whereas non ESKAPE pathogens such as Escherichia coli and Mycobacterium tuberculosis contribute to community acquired infections. Hence, targeting enzymes involved in amino acid and protein biosynthesis pathways is one such strategy for growth inhibition of these pathogens. Amino acids and their products are essential for various functions such as bacterial survivability, pathogenicity, cell wall integrity, essential mineral acquisition from surrounding or inside pathogen and activation of transporters. This review details the amino acid and protein biosynthetic pathways in pathogenic bacteria along with efficacy and translational potential of various natural and synthetic antimicrobial molecules discovered and synthesized against enzymes of these pathways for combating bacterial growth. This review also highlights promising antibacterial molecules such as quercetin, pyrazinoic acid, mupirocin and enrofloxacin etc. which are at various phases of clinical trials and hold promise for treatment of bacterial infections. Lastly, the review also lists risks such as cytotoxicity, redundancy and metabolic bypass associated with these inhibitors and also proposes future strategies such as trojan horse and combination therapy to deal with the above issues. Graphical abstract
- 21 January 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (3) , 135
Emerging therapeutic drug targets in amino acid and protein biosynthesis pathways against ESKAPE and non-ESKAPE pathogens: a comprehensive review
Overuse and misuse of antibiotics used for treating bacterial infections has resulted in ineffectiveness of the drugs and hence increase in the cases of antimicrobial resistance. This has precipitated to the need for research and development of novel strategies to target pathogenic microbes. ESKAPE pathogens include high priority pathogens such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae (sometimes K. aerogenes), Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species (e.g., E. cloacae) which are responsible for causing healthcare associated infections whereas non ESKAPE pathogens such as Escherichia coli and Mycobacterium tuberculosis contribute to community acquired infections. Hence, targeting enzymes involved in amino acid and protein biosynthesis pathways is one such strategy for growth inhibition of these pathogens. Amino acids and their products are essential for various functions such as bacterial survivability, pathogenicity, cell wall integrity, essential mineral acquisition from surrounding or inside pathogen and activation of transporters. This review details the amino acid and protein biosynthetic pathways in pathogenic bacteria along with efficacy and translational potential of various natural and synthetic antimicrobial molecules discovered and synthesized against enzymes of these pathways for combating bacterial growth. This review also highlights promising antibacterial molecules such as quercetin, pyrazinoic acid, mupirocin and enrofloxacin etc. which are at various phases of clinical trials and hold promise for treatment of bacterial infections. Lastly, the review also lists risks such as cytotoxicity, redundancy and metabolic bypass associated with these inhibitors and also proposes future strategies such as trojan horse and combination therapy to deal with the above issues. Graphical abstract
- 21 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 334 (Pt 2) , 149180
CRISPR-Cas mediated targeting of resistance genes for combating ESKAPE pathogen infections: A Review
- 21 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 334 (Pt 2) , 149180
CRISPR-Cas mediated targeting of resistance genes for combating ESKAPE pathogen infections: A Review
- 21 February 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-14
Current trends in application of CRISPR/Cas9 in gene editing and diagnostics in Neglected tropical diseases (NTDs)
Neglected tropical diseases (NTDs) include more than a dozen of diseases which despite their fatality receive less attention from the research community worldwide. High cost diagnosis of these diseases and lack of trained community which can accurately interpret them is the major drawback in the healthcare system. Nowadays, in the genetic engineering era more emphasis is given to the modern gene editing tools such as Transcription Activator-Like Effector Nucleases (TALENS), Zinc Finger Nucleases (ZFNs) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) due to their unique tailoring molecular machinery. This review article details the applicability of CRISPR/Cas9 as a modern gene editing tool in case of NTD parasites such as trypanosomatids with an aim to target their virulent genes. It has been observed through a number of studies that knocking in/out virulent genes of these parasites have led to a significant decrease in infectivity, growth rates along with morphological defects. The article also mentions various advanced CRISPR/Cas based diagnostics such as Specific High-Sensitivity Enzymatic Reporter unLOCKing (SHERLOCK) and SHERLOCK4HAT which can detect parasite concentration as low as 2 attomolar/L (aM: 10− 18) and 1 parasite/µL respectively. This review also enlists various regulatory and biosafety issues, for example ecological imbalance which can arise as a consequence of CRISPR/Cas based gene drives employed to target parasitic vectors. Despite its wide applications, CRISPR/Cas is associated with several limitations like off-target effects and ecological imbalance to name a few.
- 21 February 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-14
Current trends in application of CRISPR/Cas9 in gene editing and diagnostics in Neglected tropical diseases (NTDs)
Neglected tropical diseases (NTDs) include more than a dozen of diseases which despite their fatality receive less attention from the research community worldwide. High cost diagnosis of these diseases and lack of trained community which can accurately interpret them is the major drawback in the healthcare system. Nowadays, in the genetic engineering era more emphasis is given to the modern gene editing tools such as Transcription Activator-Like Effector Nucleases (TALENS), Zinc Finger Nucleases (ZFNs) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) due to their unique tailoring molecular machinery. This review article details the applicability of CRISPR/Cas9 as a modern gene editing tool in case of NTD parasites such as trypanosomatids with an aim to target their virulent genes. It has been observed through a number of studies that knocking in/out virulent genes of these parasites have led to a significant decrease in infectivity, growth rates along with morphological defects. The article also mentions various advanced CRISPR/Cas based diagnostics such as Specific High-Sensitivity Enzymatic Reporter unLOCKing (SHERLOCK) and SHERLOCK4HAT which can detect parasite concentration as low as 2 attomolar/L (aM: 10− 18) and 1 parasite/µL respectively. This review also enlists various regulatory and biosafety issues, for example ecological imbalance which can arise as a consequence of CRISPR/Cas based gene drives employed to target parasitic vectors. Despite its wide applications, CRISPR/Cas is associated with several limitations like off-target effects and ecological imbalance to name a few.
- 7 August 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 278 (Pt 1) , 134392
Mechanistic and structural insights into vitamin B2 metabolizing enzyme riboflavin kinase from Leishmania donovani
- 7 August 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 278 (Pt 1) , 134392
Mechanistic and structural insights into vitamin B2 metabolizing enzyme riboflavin kinase from Leishmania donovani
- 25 July 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 277 (Pt 2) , 134097
A comprehensive review on the current status of CRISPR based clinical trials for rare diseases
- 25 July 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 277 (Pt 2) , 134097
A comprehensive review on the current status of CRISPR based clinical trials for rare diseases
- 1 February 2024
- Published by Elsevier in Acta Tropica
- Vol. 252, 107139
Clotrimazole causes membrane depolarization and induces sub G0 cell cycle arrest in Leishmania donovani
- 1 February 2024
- Published by Elsevier in Acta Tropica
- Vol. 252, 107139
Clotrimazole causes membrane depolarization and induces sub G0 cell cycle arrest in Leishmania donovani
- 6 July 2023
- Published by Springer Nature in 3 Biotech
- Vol. 13 (8) , 1-15
Insights into Leishmania donovani potassium channel family and their biological functions
Leishmania donovani is the causative organism for visceral leishmaniasis. Although this parasite was discovered over a century ago, nothing is known about role of potassium channels in L. donovani. Potassium channels are known for their crucial roles in cellular functions in other organisms. Recently the presence of a calcium-activated potassium channel in L. donovani was reported which prompted us to look for other proteins which could be potassium channels and to investigate their possible physiological roles. Twenty sequences were identified in L. donovani genome and subjected to estimation of physio-chemical properties, motif analysis, localization prediction and transmembrane domain analysis. Structural predictions were also done. The channels were majorly α-helical and predominantly localized in cell membrane and lysosomes. The signature selectivity filter of potassium channel was present in all the sequences. In addition to the conventional potassium channel activity, they were associated with gene ontology terms for mitotic cell cycle, cell death, modulation by virus of host process, cell motility etc. The entire study indicates the presence of potassium channel families in L. donovani which may have involvement in several cellular pathways. Further investigations on these putative potassium channels are needed to elucidate their roles in Leishmania.
- 6 July 2023
- Published by Springer Nature in 3 Biotech
- Vol. 13 (8) , 1-15
Insights into Leishmania donovani potassium channel family and their biological functions
Leishmania donovani is the causative organism for visceral leishmaniasis. Although this parasite was discovered over a century ago, nothing is known about role of potassium channels in L. donovani. Potassium channels are known for their crucial roles in cellular functions in other organisms. Recently the presence of a calcium-activated potassium channel in L. donovani was reported which prompted us to look for other proteins which could be potassium channels and to investigate their possible physiological roles. Twenty sequences were identified in L. donovani genome and subjected to estimation of physio-chemical properties, motif analysis, localization prediction and transmembrane domain analysis. Structural predictions were also done. The channels were majorly α-helical and predominantly localized in cell membrane and lysosomes. The signature selectivity filter of potassium channel was present in all the sequences. In addition to the conventional potassium channel activity, they were associated with gene ontology terms for mitotic cell cycle, cell death, modulation by virus of host process, cell motility etc. The entire study indicates the presence of potassium channel families in L. donovani which may have involvement in several cellular pathways. Further investigations on these putative potassium channels are needed to elucidate their roles in Leishmania.